^
BIOMARKER:

PCSK9 underexpression

i
Other names: PCSK9, Proprotein Convertase Subtilisin/Kexin Type 9, NARC-1, Subtilisin/Kexin-Like Protease PC9, NARC1, Convertase Subtilisin/Kexin Type 9 Preproprotein, Hypercholesterolemia, Autosomal Dominant 3, Neural Apoptosis Regulated Convertase 1, Neural Apoptosis-Regulated Convertase 1, Proprotein Convertase 9, HCHOLA3, LDLCQ1, FHCL3
Entrez ID:
Related biomarkers:
News
Twitter
Trials
PCSK9 underexpression
Bladder Cancer
Immunotherapy
Sensitive: C3 – Early Trials
PCSK9 underexpression
Cutaneous Melanoma
Immunotherapy
Sensitive: C3 – Early Trials
PCSK9 underexpression
HCC
Immunotherapy
Sensitive: C3 – Early Trials
PCSK9 underexpression
Uveal Melanoma
Immunotherapy
Sensitive: C3 – Early Trials
PCSK9 underexpression
Urothelial Cancer
Immunotherapy
Sensitive: C3 – Early Trials
PCSK9 underexpression
Ovarian Cancer
Immunotherapy
Sensitive: C3 – Early Trials
PCSK9 underexpression
Kidney Cancer
Immunotherapy
Sensitive: C3 – Early Trials
PCSK9 underexpression
LUAD
Immunotherapy
Sensitive: C3 – Early Trials